[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352136-105":59,"doc-detail-352136-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","worldwide-innovative-network-consortium-building-a-common-global-cancer-database","Worldwide Innovative Network Consortium - Building a Common Global Cancer Database","","This review describes the Worldwide Innovative Network (WIN) Consortium’s precision-medicine effort to synthesize emerging cancer treatment evidence and to define requirements for a common global cancer database supporting precision oncology. A narrative review covers emerging treatment data, molecular profiling technologies, and existing clinicogenomic resources, emphasizing tumor characterization, subgroup definition, and capture of demographic, lifestyle, and environmental factors. It argues that inclusive, validated, governance-ready datasets enable precise multilevel analysis and AI-driven insights.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/worldwide-innovative-network-consortium-building-a-common-global-cancer-database/352136/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/worldwide-innovative-network-consortium-building-a-common-global-cancer-database/352136.png","ImageObject",300,407,{"name":92,"@type":93},"hdkawk","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of the Worldwide Innovative Network (WIN) Consortium in this review?","Question",{"text":112,"@type":113},"To synthesize emerging cancer treatment data and define requirements for a common global cancer database that can truly support precision oncology.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which types of factors does the review focus on for subgroup and tumor characterization?",{"text":117,"@type":113},"It emphasizes how tumors are characterized and how subgroups are defined, including capture of demographic, lifestyle, and environmental factors alongside molecular profiling.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is building large, diverse datasets portrayed as necessary for precision oncology?",{"text":121,"@type":113},"Because tumors are described as composites of multiple rare subgroups with distinct biology, and answering biomarker-driven questions requires large multi-institutional cohorts with racial and ethnic diversity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352136,1791073620,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985747859855,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Special Articles  \nWorldwide Innovative Network Consortium: Building a Common Global Cancer Database  \nFarhood Farahnak, PhD1 ; Waﬁk S. El-Deiry, MD, PhD, FACP2,3; Yves A. Lussier, MD, FACMI4 ; Razelle Kurzrock, MD, FACP2,5  ;  \nShai Magidi, MEng2; Catherine Bresson, MBA2 ; Shirin A. Enger, PhD1 ; Jia Liu, MD, PhD6,7,8 ; Jair Bar, MD, PhD9,10  ;  \nJeremy L. Warner, MD, MS3,11,12 ; Tobias Meissner, PhD13 ; Eitan Rubin, PhD14 ; Jens Rueter, PhD15 ; Himabindu Gaddipati, MD16; Mandar Kulkarni, PhD16 ; Zhen Chen, MD, PhD17; Sewanti Limaye, MD18 ; Rachel Elsey, PharmD13 ; Brenda M. Rubenstein, PhD3  ; Anthony M. Joshua, MD, PhD7,8 ; Humaid O. Al-Shamsi, MD19,20,21 ; Khaled M. Musallam, MD, PhD18 ; Fanny Wunder, PhD2;  \nJacques Raynaud, MD2; Guy Berchem, MD, PhD22,23,24 ; Manon Gantenbein, PhD24 ; Amal Al Omari, PhD25 ; Said Dermime, PhD26 ; Hikmat Abdel-Razeq, MD25 ; Pierre Saintigny, MD, PhD27,28 ; Andrs Cervantes, MD, PhD29,30 ; Roger R. Reddel, PhD6  ;  \nAdel T. Aref, MD, PhD6 ; Juan Martin-Liberal, MD, PhD31 ; Conxi Lzaro, PhD31 ; David Cordero Romera, PhD31 ;  \nMarina Sekacheva, MD, PhD32; Raanan Berger, MD, PhD9; C.S. Pramesh, MD33 ; Ioana Berindan-Neagoe, PhD34,35 ; Eugenia Girda, MD36; Alejandro Piris-Gimenez, PhD37,38; Carol J. Farhangfar, PhD39 ; Mohammed E. Salem, MD39 ; Rodrigo Dienstmann, MD37,40  ;  \nRamon Salazar, MD, PhD41 ; Naftali Z. Frankel, MS42; Zachary Batist, PhD43 ; Yuri Quintana, PhD, FACMI, FIAHSI, FAMIA44,45,46,47 ; and Gerald Batist, MD1  \nDOI [https://doi.org/10.1200/GO-25-00720](https://doi.org/10.1200/GO-25-00720)  \nABSTRACT  \nThis review shares the ongoing work of the global Worldwide Innovative Network (WIN) Consortium for Precision Medicine to synthesize emerging cancer treatment data and to deﬁne the requirements for a common global cancer database that can truly support precision oncology. We performed a narrative review of emerging cancer treatment data, molecular proﬁling technologies, and existing clinicogenomic databases, focusing on how tumors are characterized, how subgroups are deﬁned, and how demographic, lifestyle, and environmental factors are captured. The growth in molecular proﬁling technologies and the development of new targeted therapies are transforming cancer care. Tumors, regardless of tissue origin, are increasingly deﬁned as composites of multiple, often rare, subgroups, each with distinct biology and likely response to speciﬁc therapies, based on multidimensional proﬁling of the tumor and its microenvironment. The solution lies in building vast databases that capture racial and ethnic diversity, reﬂected in genomic data, as well as diet and lifestyle factors that may have epigenetic impact on gene expression and post-translational modiﬁcations. A truly inclusive and informative data set must reﬂect global diversity, and there are multiple examples of demography-dependent differences in genomic signals. With members caring for and studying patients with cancer across ﬁve continents, WIN is actively exploring pathways to create a global cancer database, rich in clinical and molecular detail, granular enough for precise analysis, and large enough to power artiﬁcial intelligence–driven insights, provided appropriate data quality, validation, and governance frameworks are in place. This review surveys the current landscape and outlines practical paths forward to achieve this goal.  \nACCOMPANYING CONTENT  \n Data Supplement  \nAccepted May 20, 2026  \nPublished August 13, 2026  \nJCO Global Oncol 12:e2500720 © 2026 by American Society of Clinical Oncology  \nLicensed under the Creative  \nCommons Attribution 4.0 License  \nINTRODUCTION  \nCancer remains a leading global health challenge, with millions of new cases diagnosed annually.1 Despite advances, its molecular complexity, heterogeneity, and variable treatment responses demand continuous research and innovation. Traditional cytotoxic therapies adopt a onesize-ﬁts-all approach that overlooks tumor molecular diversity, the microenvironm","cbCaidJZgKEC3WFJ","https://ap.wps.com/l/cbCaidJZgKEC3WFJ","pdf",2267576,18,"English","# Abstract\n# Introduction\n## Precision oncology and data access barriers\n## Targeted therapies and database limitations\n# Challenges and potential solutions\n## Ethical, legal, and privacy considerations","[{\"question\":\"What is the main goal of the Worldwide Innovative Network (WIN) Consortium in this review?\",\"answer\":\"To synthesize emerging cancer treatment data and define requirements for a common global cancer database that can truly support precision oncology.\"},{\"question\":\"Which types of factors does the review focus on for subgroup and tumor characterization?\",\"answer\":\"It emphasizes how tumors are characterized and how subgroups are defined, including capture of demographic, lifestyle, and environmental factors alongside molecular profiling.\"},{\"question\":\"Why is building large, diverse datasets portrayed as necessary for precision oncology?\",\"answer\":\"Because tumors are described as composites of multiple rare subgroups with distinct biology, and answering biomarker-driven questions requires large multi-institutional cohorts with racial and ethnic diversity.\"}]","Worldwide Innovative Network Consortium - Building a Common Global Cancer Database | PDF",1790097852,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da217f4ec23c93754f060962982fe40f.webp",983,1315,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de621d92ed44bec6c2a5b280c9d44bd4.webp",982,1314,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/abfb15a79b9ff35e94ce944e1e450ffb.webp",981,1312,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7413b498f8baf67121a9f6a49d52c8a8.webp",980,1311]